Q32 Bio Inc. — Director's Dealing 2024

Mar 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (QTTB)
CIK: 0001661998
Period of Report: 2024-03-25

Reporting Person: Violette Shelia M. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-25	Stock Option (Right to Buy)	$16.82	A	56413	Acquired	2034-03-24	Common Stock (56413)	Direct

Footnotes

F1: 25% of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.